Sunday - October 26, 2025
Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programs
October 07, 2025
CAMBRIDGE, Massachusetts, Oct. 7 -- Arbor Biotechnologies, a biotechnology company that says it discovers and develops genetic medicines, issued the following news release on Oct. 6, 2025:

* * *

Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programs

* Exclusive collaboration and license agreement for the development and global commercialization of Arbor's clinical-stage gene ed . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products